Testosterone Replacement Benefits Young Male Cancer Survivors, New Research Finds
University of SheffieldNew study demonstrates that testosterone replacement therapy benefits young male cancer survivors
New study demonstrates that testosterone replacement therapy benefits young male cancer survivors
Researchers at Hospital for Special Surgery (HSS) in New York City launched a nationwide survey to assess the needs of male patients and found that 58% reported feeling depressed for several days or more than half the days in the previous two weeks.
Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found fewer new cases of hepatitis C infection (commonly called HCV), despite very high rates of other sexually-transmitted infections, in HIV-negative men who have sex with men who take pre-exposure prophylaxis (PrEP) treatments.
Announcement of a new $15 million gift for University Hospitals to develop a new model for the delivery of health care to men.
Roland Taylor, 69, has faced considerable struggles in life, at times battling homelessness and addiction. Two years ago, he felt a lump in his chest, but ignored it until he discovered that it had grown. He went to the doctor and was shocked to learn that he had breast cancer.
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.
A Keck School of Medicine of USC study compared the Pinktober and Movember movements, showing that reach and engagement do not always lead people to research screening options
Highlights • Rates for all types of kidney replacement therapy in European countries were consistently higher in men than women from 1965 to 2015. • Male-to-female ratios increased with age, showing consistency over decades and for individual countries, despite changes in the causes of kidney disease. • The male-to-female ratio was higher for kidney transplantation in diabetic patients.
A Cooperative Research Center (CRC) has been established by the National Institutes of Health at three institutions including the Lawrence Livermore National Laboratory (LLNL), the University of California, Irvine (UCI) and the University of California, Davis, with a single goal to enhance and accelerate the development of vaccines for Chlamydia trachomatis genital infections.
Routine use of opioids after vasectomy doesn't improve pain control, but is associated with a substantial rate of persistent opioid use in the months after the procedure, reports a study in the October issue of The Journal of Urology®, Official Journal of the American Urological Association (AUA). The Journal is published in the Lippincott portfolio by Wolters Kluwer.
New discovery could transform outlook for men with fertility problems
Researchers from the UCLA Jonsson Comprehensive Cancer Center and other institutions in the U.S., Canada, the United Kingdom and Singapore, have identified 1,178 biomarkers in men’s genomes — the complete set of genetic material inherited from one’s parents — that predict how an individual person’s prostate cancer will grow. The finding suggests that predicting how a person’s cancer will evolve may lie in their inherited DNA.
Results from the first long-term cohort study of more than 36,000 Japanese men over decades suggest an association between eating mushrooms and a lower risk of prostate cancer.
As Breast Cancer Awareness Month kicks off this October, a UNLV public health professor is reminding people that men are also at risk. Statistics show that about 1 in 8 U.S. women will develop invasive breast cancer over the course of her lifetime, leading to it be seen primarily as a “woman’s disease.” But that view unintentionally creates a health disparity for men, who — with a lifetime risk of developing breast cancer sitting at about 1 in 883 — often face barriers to diagnosis and treatment due to a lack of awareness among the general public, policymakers, and health care professionals, says Marya Shegog, director of health programs at The Lincy Institute at UNLV.
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy. The phase II trial found that radiation therapy can generate an immune system response not previously believed possible in this type of cancer. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
A secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men and calls for rethinking treatment guidelines based on a patient’s post-operative prostate-specific antigen (PSA) level. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).
PTEN, a tumor suppressor gene mutated in about 20% of prostate cancers, relies on another gene, ARID4B, to function. These findings were published by George Washington University Cancer Center researchers in Nature Communications.
Loyola Medicine is among the first centers to offer a new minimally invasive prostate cancer biopsy that minimizes the risk of infection and may increase the cancer detection rate. It's called the transperineal prostate biopsy.
Atlantic Health System Cancer Care at Overlook Medical Center is now offering a highly advanced technology that will enhance the ability of physicians to diagnose, stage and treat prostate cancer. The UroNav Fusion Biopsy System fuses pre-biopsy magnetic resonance imaging (MRI) images of the prostate with ultrasound-guided 3-D images in real time, allowing for excellent imaging of the prostate and any abnormal changes (lesions) that may or may not be cancerous.
Michigan's two comprehensive cancer center, the University of Michigan Rogel Cancer and the Barbara Ann Karmanos Cancer Institute, have received a prestigious $9.2 million grant from the National Cancer Institute for prostate cancer research.
UC San Francisco announced Thursday it will establish the UCSF Benioff Initiative for Prostate Cancer Research, made possible by a $35 million gift from Marc and Lynne Benioff.
Prostate cancer doesn't have the spell the end of a healthy sex life. Survivorship programs promote sexual recovery after cancer treatment.
Men at high risk of developing breast cancer may benefit from mammography, or breast X-ray, screening for the disease, a new study shows.
Blocking a kinase known as CDK7 sets off a chain reaction that results in the death of prostate cancer cells that have spread and are resistant to standard therapies
Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate.
Former NFL players reporting concussion symptoms following head injury more likely to report erectile dysfunction and low testosterone levels Players reporting the most concussion symptoms have nearly twice the risk of ED, compared with players with the fewest symptoms The elevated risk was present even when researchers accounted for other possible drivers of ED as well as among younger players who suffered concussions Researchers caution that the exact biological mechanisms remain to be elucidated, but injury to the pituitary gland and downstream hormonal changes may be one possible explanation Players with ED should seek prompt evaluation for this common, highly treatable condition, which can also indicate the presence of other diseases, including cardiovascular illness and diabetes Clinicians treating patients with head trauma should inquire proactively about symptoms of ED and low testosterone Results may be relevant in other sports where head injuries are common, including h
With National Prostate Health Month quickly approaching in September, the Prostate Cancer Program at the Cancer Center at Beth Israel Deaconess Medical Center has several expert sources that may be helpful for stories you are working on now or in the future.
Common prostate cancer therapy may increase short-term risk of death in patients with pre-existing cardiovascular conditions.
According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their lifetime. It’s both the second most common cancer and second most common cause of cancer death in American men. Early detection is critical and can increase a man’s chances of survival. A Rensselaer researcher recently received the latest in a series of grants aimed at advancing current imaging technology, and developing new tools for diagnosis and treatment delivery. The most recent award, from the National Institute of Biomedical Imaging and Bioengineering, will help him improve an image fusion technique — currently used clinically to enable biopsies for diagnosis — without external tracking devices.
BIDMC podiatric surgeon Thanh Dinh, DPM, shares five simple tips for keeping your feet feeling their best.
On August 4, a special session at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo will shed much-needed light on the nuances of direct-to-consumer genetic testing.
Researchers from the UCLA Jonsson Comprehensive Cancer Center undertook a head-to-head comparison of two imaging techniques and have concluded that prostate-specific membrane antigen imaging is more effective in detecting the location of the prostate cancer recurrence.
Discovery shows how difficult-to-treat prostate cancer evades immune system and reports pre-clinical development of novel treatment and potential for combination use with immunotherapy drugs.
It is well understood that urban black males are at a disproportionately high risk of poor health outcomes. But little is known about how the neighborhood environments where these men live contribute to their health.
The style of tackling used in rugby may be associated with a lower force of impact than the style used in football, according to a preliminary study of college athletes released today that will be presented at the American Academy of Neurology Sports Concussion Conference in Indianapolis July 26–28, 2019.
The first step in identifying and treating infertility is often rigorous testing for women. However, only 50 percent of infertility is attributable to the female partner alone, 50 percent of couples have a male factor, according to Nikhil Gupta, MD, assistant professor of surgery. In May 2018, Dr. Gupta became the first andrologist and male sexual function subspecialist appointed to the faculty of Rutgers Robert Wood Johnson Medical School. He focuses on the treatment of male infertility, sexual dysfunction, benign prostate hyperplasia (non-cancerous enlarged prostate) and erectile dysfunction.
In the first of a kind study, plastic surgeons at Georgetown University Medical Center found that when a man chose to have a nip or a tuck on his face, it significantly increased perceptions of attractiveness, likeability, social skills, or trustworthiness.
The males of one species of butterfly are more attracted to females that are active, not necessarily what they look like, according to a recent research conducted at Augustana University.The paper, “Behaviour before beauty: Signal weighting during mate selection in the butterfly Papilio polytes,” found that males of the species noticed the activity levels of potential female mates, not their markings.
Prostate cancer represents a major health challenge and there is currently no effective treatment once it has advanced to the aggressive, metastatic stage. A new has revealed a key cellular mechanism that contributes to aggressive prostate cancer, and supporting a new clinical trial.
A monthly roundup of research briefs showcasing recent scientific advances led by Beth Israel Deaconess Medical Center faculty.
A team of researchers from UCLA and the University of Toronto have identified a new biomarker found in urine that can help detect aggressive prostate cancer, potentially saving hundreds of thousands of men each year from undergoing unnecessary surgeries and radiotherapy treatments.
Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments and is safe for patients
The Academy for Eating Disorders (AED) and National Association for Males with Eating Disorders Respond to the Media Coverage of Restrictive Diets as ‘Biohacking’
A new study from researchers at the University of Michigan Rogel Cancer Center finds that the gene FOXA1 overrides normal biology in three different ways to drive prostate cancer. They refer to the three classes as FAST, FURIOUS, and LOUD to reflect their unique features.
New research points toward testosterone-boosting supplements as having little or no known effect
Media are invited to stream this event taking place during NATA’s 70th Clinical Symposia in Las Vegas, 12:00 PM EDT / 9:00 AM PDT
World Trade Center (WTC) responders with prostate cancer showed signs that exposure to dust from the World Trade Center site had activated chronic inflammation in their prostates, which may have contributed to their cancer, according to a study by Mount Sinai researchers in Molecular Cancer Research in June.
Aria Olumi, MD, Chief of Urologic Surgery at Beth Israel Deaconess Medical Center, explains the importance of men knowing their prostate-specific antigen (PSA) number.
James Heckman, MD, Assistant Medical Director of Healthcare Associates at BIDMC and Aria Olumi, MD, Chief of Urologic Surgery at BIDMC, share tips for improving men's health.